Valuation: Exact Sciences Corporation

Market Cap 2TCr 1.73TCr 1.62TCr 1.48TCr 2.79TCr 1,91000Cr 2.83TCr 19TCr 7.46TCr 96TCr 7.52TCr 7.36TCr 3,18200Cr P/E 2024
-10.1x
P/E 2025 -92.2x
Enterprise Value 2.16TCr 1.87TCr 1.75TCr 1.6TCr 3.01TCr 2,06000Cr 3.06TCr 20TCr 8.04TCr 1,03000Cr 8.11TCr 7.93TCr 3,43200Cr EV / Sales 2024
4.4x
EV / Sales 2025 6.42x
Free-Float
98.24%
Yield 2024 *
-
Yield 2025 -
1 day+0.95%
6 months+1.51%
Current year+3.30%
Current year 101.51
Extreme 101.51
104.98
1 year 41.15
Extreme 41.15
104.98
3 years 38.81
Extreme 38.8118
104.98
5 years 29.27
Extreme 29.27
108.99
10 years 13.05
Extreme 13.05
159.54
Date Insider Type Main position Quantity % Market Cap.
23/03/26 Free

Head of Human Resources

3,29,891 0.1728%
23/03/26 Issuer sale

General Counsel

93,932 0.0492%
27/02/26 Fiscal year

Chief Executive Officer

1,68,201 0.0882%
Change 5-day change 1-year change 3-year change Capi.($)
+0.95%-.--%+155.94%+27.07% 2TCr
+2.09%+10.13%+108.61%+296.42% 397.87Cr
-2.01%+3.17%+69.05%+81.88% 379.61Cr
+0.95%+48.32%+203.32%-10.99% 287.18Cr
+0.81%-1.63%+293.23%+386.26% 241.55Cr
+1.83%+7.08%-22.02%-32.36% 227.28Cr
+4.22%+5.54%+9.93% - 125.84Cr
+6.40%+15.17%+2.33%+32.54% 93Cr
-2.57%-5.45%+175.91%-41.07% 93Cr
+1.75%+4.22%-36.35%-5.07% 53Cr
Average +1.44%+7.11%+96.00%+81.63% 390.14Cr
Weighted average by Cap. +0.98%+4.95%+133.75%+75.48%

Financials

2024 2025
Net sales 275.89Cr 238.84Cr 223.24Cr 204.03Cr 384.48Cr 26TCr 390.49Cr 2.62TCr 1.03TCr 13TCr 1.04TCr 1.01TCr 44TCr 324.7Cr 281.09Cr 262.74Cr 240.13Cr 452.5Cr 31TCr 459.58Cr 3.08TCr 1.21TCr 15TCr 1.22TCr 1.19TCr 52TCr
Net income -102.89Cr -89Cr -83Cr -76Cr -143.38Cr -9.81TCr -145.62Cr -976.25Cr -383.07Cr -4.91TCr -386.33Cr -377.9Cr -16TCr -21Cr -18Cr -17Cr -15Cr -29Cr -1.98TCr -29Cr -197.32Cr -77Cr -992.19Cr -78Cr -76Cr -3.3TCr
Net Debt 173.77Cr 150.43Cr 140.61Cr 128.51Cr 242.17Cr 17TCr 245.96Cr 1.65TCr 647Cr 8.29TCr 652.49Cr 638.26Cr 28TCr 157.01Cr 135.92Cr 127.05Cr 116.12Cr 218.81Cr 15TCr 222.23Cr 1.49TCr 584.6Cr 7.49TCr 589.56Cr 576.7Cr 25TCr
Logo Exact Sciences Corporation
Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. It offers a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. Its portfolio includes brands such as Cologuard and Oncotype DX, along with solutions like Cancerguard for blood-based analysis of molecular information across multiple cancers and Oncodetect for molecular residual disease and recurrence monitoring. Its flagship screening products, the Cologuard and Cologuard Plus tests, are patient-friendly, non-invasive, stool-based DNA (sDNA) screening tests that utilize a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Its Cancerguard test is designed to detect multiple cancers in their earliest stages from a single blood draw. It offers predefined genetic tests for all clinically relevant genes, and whole genome (PGnome) sequencing tests.
Employees
7,150
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
  1. Stock Market
  2. Stocks
  3. EXAS Stock